SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Akram Asif) srt2:(2018)"

Search: WFRF:(Akram Asif) > (2018)

  • Result 1-2 of 2
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Akram, Asif, 1978, et al. (author)
  • TRUST, PRIVACY AND TRANSPARENCY WITH BLOCK- CHAIN TECHNOLOGY IN LOGISTICS
  • 2018
  • In: Proceedings of the Twelfth Mediterranean Conference on Information Systems. - 9789607260611
  • Conference paper (peer-reviewed)abstract
    • Since the introduction of blockchain over a decade ago, many industries and industrial sectors are ex- ploring the potentials of the technology. In line with the trend, logistics sector is not an exception and is investigation various dynamics associated with the implementation of the technology. This study fo- cuses on the linking between the capabilities of blockchain technology and trust, privacy and transpar- ency. In order to explore dynamics of the linkage, the study used case study as a method for the inquiry. These have been common issues in logistics which the existing information solutions are unable in re- solving to a greater extent.. The results shows that blockchain technology has the capability to build trust among unknown industry players while maintaining a sufficient level of privacy and transparency at the same time. Overall, the study presents useful insights by contributing to the major issues in logis- tics and supply chain when an innovative digital technology is put into action.
  •  
2.
  • Vallejo-Vaz, Antonio J., et al. (author)
  • Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
  • 2018
  • In: Atherosclerosis. - : ELSEVIER IRELAND LTD. - 0021-9150 .- 1879-1484. ; 277, s. 234-255
  • Journal article (peer-reviewed)abstract
    • Background and aims: Management of familial hypercholesterolaemia (FH) may vary across different settings due to factors related to population characteristics, practice, resources and/or policies. We conducted a survey among the worldwide network of EAS FHSC Lead Investigators to provide an overview of FH status in different countries. Methods: Lead Investigators from countries formally involved in the EAS FHSC by mid-May 2018 were invited to provide a brief report on FH status in their countries, including available information, programmes, initiatives, and management. Results: 63 countries provided reports. Data on FH prevalence are lacking in most countries. Where available, data tend to align with recent estimates, suggesting a higher frequency than that traditionally considered. Low rates of FH detection are reported across all regions. National registries and education programmes to improve FH awareness/knowledge are a recognised priority, but funding is often lacking. In most countries, diagnosis primarily relies on the Dutch Lipid Clinics Network criteria. Although available in many countries, genetic testing is not widely implemented (frequent cost issues). There are only a few national official government programmes for FH. Under-treatment is an issue. FH therapy is not universally reimbursed. PCSK9-inhibitors are available in similar to 2/3 countries. Lipoprotein-apheresis is offered in similar to 60% countries, although access is limited. Conclusions: FH is a recognised public health concern. Management varies widely across countries, with overall suboptimal identification and under-treatment. Efforts and initiatives to improve FH knowledge and management are underway, including development of national registries, but support, particularly from health authorities, and better funding are greatly needed.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-2 of 2

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view